UNH · Unitedhealth Group Inc
$399.66
+3.36 (+0.85%)
At close · Sep 2
Market Cap
$358.12B
Shares
897.59M
UNH metrics
92 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$399.66
Market cap
$358.12B
Price action
19 metricsPrice change (1W)
-0.1%
Price change (30D)
-4.6%
Price change (3M)
+4.9%
Price change (6M)
+37.0%
Price change (YTD)
+20.1%
Price change (1Y)
+27.9%
Trailing year
Price change (5Y)
-5.0%
52-week high
$436.35
52-week low
$259.02
Change from 52-week high
-9.2%
Change from 52-week low
+53.0%
Annualized volatility
35.6%
Beta
0.5
RSI (14D)
46.1
Price vs SMA 50
-3.9%
Price vs SMA 200
+13.1%
Avg volume (3M)
5.58M
Relative volume
0.7
Average dollar volume
$2.29B
Company
3 metricsSector
Healthcare
Industry
Healthcare Plans
Shares outstanding
897.59M
Valuation
12 metricsP / E (TTM)
25.4
Trailing earnings · reciprocal yield 3.9%
PEG ratio
0.4
EV / revenue
0.9×
reciprocal yield 114.1%
EV / EBITDA
15.2×
reciprocal yield 6.6%
EV / EBIT
18.2×
reciprocal yield 5.5%
P / sales
0.8×
reciprocal yield 127.6%
P / book
3.4
reciprocal yield 29.6%
FCF yield
6.7%
TTM · current market cap
Buyback yield
0.5%
P / FCF
14.9
reciprocal yield 6.7%
P / operating cash flow
13.1
reciprocal yield 7.7%
Earnings yield
4.0%
Historical valuation
8 metricsP / E historical average (3Y)
24.6×
reciprocal yield 4.1%
P / E historical average (5Y)
24.8×
reciprocal yield 4.0%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
2.3%
Trailing 12 months
Payout ratio
57.3%
Shareholder yield
2.8%
Dividend / share (TTM)
$8.95
Dividend growth YoY
+5.2%
Dividend growth streak
5
Last ex-dividend
2026-06-15
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-16
Profitability
9 metricsGross margin
88.6%
Operating margin
4.8%
Trailing 12 months
Net margin
3.1%
Gross profit (TTM)
—
Operating profit (TTM)
$21.68B
Net income (TTM)
$14.12B
Trailing 12 months
Diluted EPS (TTM)
$15.58
FCF margin
5.2%
Effective tax rate
14.5%
Growth
11 metricsRevenue growth YoY
+0.4%
Year over year
Net income growth YoY
+61.0%
Revenue (TTM)
$450.13B
Trailing 12 months
EPS growth YoY
+61.5%
Shares change YoY
-0.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.4%
Revenue CAGR (5Y)
+11.7%
EPS CAGR (3Y)
-14.5%
EPS CAGR (5Y)
-3.8%
FCF CAGR (3Y)
-11.8%
FCF CAGR (5Y)
-4.4%
Quality
14 metricsReturn on equity
13.5%
Return on assets
4.6%
Debt / equity
0.7
Current ratio
0.8
EBITDA (TTM)
$25.96B
Free cash flow (TTM)
$23.62B
Quick ratio
—
Interest coverage
5.6
Net debt / EBITDA
1.6
Return on invested capital
12.7%
Trailing 12 months
Net cash
−$41.86B
Latest balance sheet
Cash & equivalents
$28.59B
Total assets
$309.73B
Total debt
$73.33B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$27.02B
Capital expenditures (TTM)
$3.40B
R&D (TTM)
—
SG&A (TTM)
$61.88B
Stock compensation (TTM)
$1.02B
R&D / revenue
—
Stock compensation / revenue
0.2%
Ownership (13F)
3 metrics13F filers
3,372
13F filer change QoQ
+306
Institutional ownership
95.2%
Short interest
3 metricsShort interest
1.7%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
−$660,910
Insider-sentiment score
50 / 100
Risk flags
1 metricsGoing concern
—